High-resolution genomic analysis in Waldenström's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas

Clinical Lymphoma and Myeloma

Volumn 9, Issue 1, 2009, Pages 39-42

  Braggio, Esteban ^a   Keats, Jonathan ^a   Leleu, Xavier ^b   Wier, Scott Van ^a   Jimenez Zepeda, Victor Hugo ^a   Schop, Roelandt ^a   Chesi, Marta ^a   Barrett, Michael ^c   Stewart, Alexander Keith ^a   Dogan, Ahmet ^d   Bergsagel, Peter Leif ^a   Ghobrial, Irene ^b   Fonseca, Rafael ^a  

^a MAYO CLINIC   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d MAYO CLINIC   (United States)

Author keywords

ACGH; Comparative genomic analysis; Waldenstr m

Indexed keywords

ARTICLE; BONE MARROW; CHROMOSOME 13Q; CHROMOSOME 18Q; CHROMOSOME 4Q; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIPLE MYELOMA; PATHOGENESIS; WALDENSTROEM MACROGLOBULINEMIA; COHORT ANALYSIS; GENETICS; HUMAN GENOME; KARYOTYPING;

CHROMOSOME ABERRATIONS; COHORT STUDIES; COMPARATIVE GENOMIC HYBRIDIZATION; GENOME, HUMAN; HUMANS; KARYOTYPING; LYMPHOMA, B-CELL, MARGINAL ZONE; WALDENSTROM MACROGLOBULINEMIA;

EID: 67649510148     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2009.n.009     Document Type: Article

References (20)

1. Fonseca R, Hayman S. Waldenstrom macroglobulinaemia. Br J Haematol 2007; 138:700-20.
2. Schop RF, Kuehl WM, Van Wier SA, et al. Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood 2002; 100:2996-3001.
3. Schop RF, Van Wier SA, Xu R, et al. 6q deletion discriminates Waldenstrom macroglobulinemia from IgM monoclonal gammopathy of undetermined significance. Cancer Genet Cytogenet 2006; 169:150-3.
4. Terre C, Nguyen-Khac F, Barin C, et al. Trisomy 4, a new chromosomal abnormality in Waldenstrom's macroglobulinemia: a study of 39 cases. Leukemia 2006; 20:1634-6.
5. Schop RF, Jalal SM, Van Wier SA, et al. Deletions of 17p13.1 and 13q14 are uncommon in Waldenstrom macroglobulinemia clonal cells and mostly seen at the time of disease progression. Cancer Genet Cytogenet 2002; 132:55-60.
6. Chng WJ, Schop RF, Price-Troska T, et al. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood 2006; 108:2755-63.
7. Gutierrez N C, Ocio EM, de Las Rivas J, et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia 2007; 21:541-9.
8. Hatjiharissi E, Ngo H, Leontovich, AA, et al. M. Proteomic analysis of waldenstrom macroglobulinemia. Cancer Res 2007; 67:3777-84.
9. Amiel A, Mulchanov I, Elis A, et al. Deletion of 6q27 in chronic lymphocytic leukemia and multiple myeloma detected by fluorescence in situ hybridization. Cancer Genet Cytogenet 1999; 112:53-6.
10. Cigudosa JC, Parsa NZ, Louie DC, et al. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer 1999; 25:123-33.
11. Tilly H, Rossi A, Stamatoullas A, et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994; 84:1043-9.
12. Offit K, Louie DC, Parsa NZ, et al. Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23). Blood 1994; 83:2611-8.
13. Honma K, Tsuzuki S, Nakagawa M, et al. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Genes Chromosomes Cancer 2008; 47:1-7.
14. Pasqualucci L, Compagno M, Houldsworth J, et al. Inactivation of the PRDM1/ BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 2006; 203:311-7.
15. Thelander EF, Ichimura K, Corcoran M, et al. Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia. Leuk Lymphoma 2008; 49:477-87.
16. Ferreira BI, Garcia JF, Suela J, et al. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. Haematologica 2008; 93:670-9.
17. Streubel B, Simonitsch-Klupp I, Mullauer L, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004; 18:1722-6.
18. Dierlamm J, Pittaluga S, Wlodarska I, et al. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 1996; 87:299-307.
19. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002; 99:15524-9.
20. Bonci D, Coppola V, Musumeci M, et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008; 14:1271-7.